Literature DB >> 23808590

Dysregulation of macrophage activation profiles by engineered nanoparticles.

Vamsi Kodali1, Matthew H Littke, Susan C Tilton, Justin G Teeguarden, Liang Shi, Charles W Frevert, Wei Wang, Joel G Pounds, Brian D Thrall.   

Abstract

Although the potential human health impacts from exposure to engineered nanoparticles (ENPs) are uncertain, past epidemiological studies have established correlations between exposure to ambient air pollution particulates and the incidence of pneumonia and lung infections. Using amorphous silica and superparamagnetic iron oxide (SPIO) as model high production volume ENPs, we examined how macrophage activation by bacterial lipopolysaccharide (LPS) or the lung pathogen Streptococcus pneumoniae is altered by ENP pretreatment. Neither silica nor SPIO treatment elicited direct cytotoxic or pro-inflammatory effects in bone marrow-derived macrophages. However, pretreatment of macrophages with SPIO caused extensive reprogramming of nearly 500 genes regulated in response to LPS challenge, hallmarked by exaggerated activation of oxidative stress response pathways and suppressed activation of both pro- and anti-inflammatory pathways. Silica pretreatment altered regulation of only 67 genes, but there was strong correlation with gene sets affected by SPIO. Macrophages exposed to SPIO displayed a phenotype suggesting an impaired ability to transition from an M1 to M2-like activation state, characterized by suppressed IL-10 induction, enhanced TNFα production, and diminished phagocytic activity toward S. pneumoniae. Studies in macrophages deficient in scavenger receptor A (SR-A) showed SR-A participates in cell uptake of both the ENPs and S. pneumonia and co-regulates the anti-inflammatory IL-10 pathway. Thus, mechanisms for dysregulation of innate immunity exist by virtue that common receptor recognition pathways are used by some ENPs and pathogenic bacteria, although the extent of transcriptional reprogramming of macrophage function depends on the physicochemical properties of the ENP after internalization. Our results also illustrate that biological effects of ENPs may be indirectly manifested only after challenging normal cell function. Nanotoxicology screening strategies should therefore consider how exposure to these materials alters susceptibility to other environmental exposures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23808590      PMCID: PMC3756554          DOI: 10.1021/nn402145t

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  55 in total

1.  The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles.

Authors:  Mohamed S Arredouani; Zhiping Yang; Amy Imrich; Yaoyu Ning; Guozhong Qin; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-04       Impact factor: 6.914

2.  Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains.

Authors:  Ying Chao; Milan Makale; Priya Prakash Karmali; Yuriy Sharikov; Igor Tsigelny; Sergei Merkulov; Santosh Kesari; Wolf Wrasidlo; Erkki Ruoslahti; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2012-04-26       Impact factor: 4.774

3.  Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution.

Authors:  C Arden Pope; Richard T Burnett; Michael J Thun; Eugenia E Calle; Daniel Krewski; Kazuhiko Ito; George D Thurston
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

4.  Magnetic particle detection (MPD) for in-vitro dosimetry.

Authors:  Kevin R Minard; Matthew H Littke; Wei Wang; Yijia Xiong; Justin G Teeguarden; Brian D Thrall
Journal:  Biosens Bioelectron       Date:  2012-12-08       Impact factor: 10.618

5.  Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A.

Authors:  Koji Kuronuma; Hitomi Sano; Kazunori Kato; Kazumi Kudo; Naoki Hyakushima; Shin-ichi Yokota; Hiroki Takahashi; Nobuhiro Fujii; Hiroshi Suzuki; Tatsuhiko Kodama; Shosaku Abe; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2004-03-01       Impact factor: 5.157

6.  IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-gamma.

Authors:  F Capsoni; F Minonzio; A M Ongari; V Carbonelli; A Galli; C Zanussi
Journal:  J Leukoc Biol       Date:  1995-09       Impact factor: 4.962

7.  Differences in gene expression and cytokine production by crystalline vs. amorphous silica in human lung epithelial cells.

Authors:  Timothy N Perkins; Arti Shukla; Paul M Peeters; Jeremy L Steinbacher; Christopher C Landry; Sherrill A Lathrop; Chad Steele; Niki L Reynaert; Emiel F M Wouters; Brooke T Mossman
Journal:  Part Fibre Toxicol       Date:  2012-02-02       Impact factor: 9.400

8.  Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages.

Authors:  Jeb S Orr; Michael J Puglisi; Kate L J Ellacott; Carey N Lumeng; David H Wasserman; Alyssa H Hasty
Journal:  Diabetes       Date:  2012-06-29       Impact factor: 9.461

9.  ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies.

Authors:  Paul M Hinderliter; Kevin R Minard; Galya Orr; William B Chrisler; Brian D Thrall; Joel G Pounds; Justin G Teeguarden
Journal:  Part Fibre Toxicol       Date:  2010-11-30       Impact factor: 9.400

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  43 in total

Review 1.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

2.  Implications of scavenger receptors in the safe development of nanotherapeutics.

Authors:  Jonathan H Shannahan; Wei Bai; Jared M Brown
Journal:  Receptors Clin Investig       Date:  2015

3.  A proteome-wide assessment of the oxidative stress paradigm for metal and metal-oxide nanomaterials in human macrophages.

Authors:  Tong Zhang; Matthew J Gaffrey; Dennis G Thomas; Thomas J Weber; Becky M Hess; Karl K Weitz; Paul D Piehowski; Vladislav A Petyuk; Ronald J Moore; Wei-Jun Qian; Brian D Thrall
Journal:  NanoImpact       Date:  2019-11-23

4.  Nanoparticle Design Strategies for Effective Cancer Immunotherapy.

Authors:  Praveena Velpurisiva; Aniket Gad; Brandon Piel; Rahul Jadia; Prakash Rai
Journal:  J Biomed (Syd)       Date:  2017

Review 5.  Mass spectrometry-based proteomics for system-level characterization of biological responses to engineered nanomaterials.

Authors:  Tong Zhang; Matthew J Gaffrey; Brian D Thrall; Wei-Jun Qian
Journal:  Anal Bioanal Chem       Date:  2018-06-08       Impact factor: 4.142

6.  Immune responses to engineered nanomaterials: current understanding and challenges.

Authors:  Nasser B Alsaleh; Jared M Brown
Journal:  Curr Opin Toxicol       Date:  2017-11-24

7.  Macrophage silica nanoparticle response is phenotypically dependent.

Authors:  Heather L Herd; Kristopher T Bartlett; Joshua A Gustafson; Lawrence D McGill; Hamidreza Ghandehari
Journal:  Biomaterials       Date:  2015-03-23       Impact factor: 12.479

8.  Manually curated transcriptomics data collection for toxicogenomic assessment of engineered nanomaterials.

Authors:  Laura Aliisa Saarimäki; Antonio Federico; Iseult Lynch; Anastasios G Papadiamantis; Andreas Tsoumanis; Georgia Melagraki; Antreas Afantitis; Angela Serra; Dario Greco
Journal:  Sci Data       Date:  2021-02-08       Impact factor: 6.444

9.  Effects of engineered nanomaterial exposure on macrophage innate immune function.

Authors:  Glen DeLoid; Beatriz Casella; Sandra Pirela; Rose Filoramo; Georgios Pyrgiotakis; Philip Demokritou; Lester Kobzik
Journal:  NanoImpact       Date:  2016-07-25

10.  Exposure to silver nanoparticles primes mast cells for enhanced activation through the high-affinity IgE receptor.

Authors:  Nasser B Alsaleh; Ryan P Mendoza; Jared M Brown
Journal:  Toxicol Appl Pharmacol       Date:  2019-09-05       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.